>drugbank_target|O75469 Nuclear receptor subfamily 1 group I member 2 (DB00163; DB00239; DB00252; DB00255; DB00257; DB00312; DB00421; DB00431; DB00499; DB00503; DB00530; DB00531; DB00532; DB00564; DB00675; DB00682; DB00754; DB00783; DB00834; DB00849; DB00977; DB01026; DB01039; DB01045; DB01068; DB01110; DB01115; DB01127; DB01138; DB01174; DB01181; DB01220; DB01229; DB01234; DB01248; DB01393; DB01708; DB02789; DB04824; DB04930; DB06777; DB08604; DB08864; DB11087; DB11605; DB13179; DB13873; DB13952; DB13953; DB13954; DB13955; DB13956; DB14001; DB14002; DB14649)
MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATGYHFNVMTCEG
CKGFFRRAMKRNARLRCPFRKGACEITRKTRRQCQACRLRKCLESGMKKEMIMSDEAVEE
RRALIKRKKSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSS
GCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLL
PHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWE
CGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHR
VVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPF
ATPLMQELFGITGS
